Active Ingredient History

NOW
  • Now
Nicergoline, sold under the brand name Sermion among others, is an ergot derivative used to treat senile dementia and other disorders with vascular origins. Internationally it has been used for frontotemporal dementia as well as early onset in Lewy body dementia and Parkinson's dementia. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs. Unlike many other ergolines, such as ergotamine, nicergoline is not associated with cardiac fibrosis.   Wikipedia

  • SMILES: CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc4cn(C)c5cccc2c45
  • InChIKey: YSEXMKHXIOCEJA-FVFQAYNVSA-N
  • Mol. Mass: 484.39
  • ALogP: 3.91
  • ChEMBL Molecule:
More Chemistry
cergodum | duracebrol | nicergolent | nicergolin | nicergolina | nicergoline | nicergolinum | nicotergoline | sermion

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue